Form 8-K FATE THERAPEUTICS INC For: Aug 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Fate Therapeutics (FATE) Tops Q2 EPS by 7c
August 12, 2014 4:28 PM EDTFate Therapeutics (NASDAQ: FATE) reported Q2 EPS of ($0.30), $0.07 better than the analyst estimate of ($0.37).
For earnings history and earnings-related data on Fate Therapeutics (FATE) click here.
... More
